KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Return on Equity: 2019-2025

Historic Return on Equity for BioNTech SE (BNTX) over the last 6 years, with Sep 2025 value amounting to -0.02%.

  • BioNTech SE's Return on Equity fell 2.00% to -0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.02%, marking a year-over-year decrease of 2.00%. This contributed to the annual value of -0.03% for FY2024, which is 8.00% down from last year.
  • Per BioNTech SE's latest filing, its Return on Equity stood at -0.02% for Q3 2025, which was down 4.03% from -0.02% recorded in Q2 2025.
  • Over the past 5 years, BioNTech SE's Return on Equity peaked at 2.05% during Q3 2021, and registered a low of -0.04% during Q1 2025.
  • For the 3-year period, BioNTech SE's Return on Equity averaged around 0.10%, with its median value being 0.00% (2024).
  • Its Return on Equity has fluctuated over the past 5 years, first soared by 215bps in 2021, then crashed by 130bps in 2023.
  • Quarterly analysis of 5 years shows BioNTech SE's Return on Equity stood at 2.05% in 2021, then crashed by 115bps to 0.90% in 2022, then plummeted by 83bps to 0.07% in 2023, then dropped by 11bps to -0.04% in 2024, then fell by 2bps to -0.02% in 2025.
  • Its Return on Equity stands at -0.02% for Q3 2025, versus -0.02% for Q2 2025 and -0.04% for Q1 2025.